The effect of diet and cardiovascular risk on ovarian aging in cynomolgus monkeys (Macaca fascicularis)

Menopause

Volumn 17, Issue 4, 2010, Pages 741-748

  Appt, Susan E ^a   Chen, Haiying ^a   Goode, Amanda K ^a   Hoyer, Patricia B ^b   Clarkson, Thomas B ^a   Adams, Michael R ^a   Wilson, Mark E ^c   Franke, Adrian A ^d   Kaplan, Jay R ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^c EMORY UNIVERSITY   (United States)

^d UNIVERSITY OF HAWAII CANCER CENTER   (United States)

Author keywords

Cardiovascular disease; Diet; Menopause; Monkey; Ovary

Indexed keywords

C REACTIVE PROTEIN; CASEIN; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 6; ISOFLAVONE; LACTALBUMIN; MONOCYTE CHEMOTACTIC PROTEIN 1; MUELLERIAN INHIBITING FACTOR; SATURATED FATTY ACID; SOYBEAN PROTEIN; ANDROSTENEDIONE; ESTRADIOL; ISOFLAVONE DERIVATIVE; LIPID; TESTOSTERONE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; EXPERIMENTAL MONKEY; FEMALE; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; NONHUMAN; OVARY DEVELOPMENT; OVARY FOLLICLE; PROTEIN INTAKE; AGING; ANIMAL; BLOOD; DIET; ILIAC ARTERY; MACACA FASCICULARIS; OVARIECTOMY; PATHOLOGY; PHYSIOLOGY; RANDOMIZATION; RETROSPECTIVE STUDY;

AGING; ANDROSTENEDIONE; ANIMALS; ANTI-MULLERIAN HORMONE; ATHEROSCLEROSIS; C-REACTIVE PROTEIN; CASEINS; CHEMOKINE CCL2; DIET; ESTRADIOL; FEMALE; ILIAC ARTERY; INTERLEUKIN-6; ISOFLAVONES; LACTALBUMIN; LIPIDS; MACACA FASCICULARIS; OVARIAN FOLLICLE; OVARIECTOMY; RANDOM ALLOCATION; RETROSPECTIVE STUDIES; SOYBEAN PROTEINS; TESTOSTERONE;

EID: 77954959666     PISSN: 10723714     EISSN: None     Source Type: Journal    
DOI: 10.1097/gme.0b013e3181d20cd2     Document Type: Article

References (54)

1. Derby CA, FitzGerald G, Lasser NL, Pasternak RC. Application of national screening criteria for blood pressure and cholesterol to perimen-opausal women: prevalence of hypertension and hypercholesterolemia in the Study of Women's Health Across the Nation. Prev Cardiol 2006;9: 150-159.
2. Derby CA, Crawford SL, Pasternak RC, Sowers M, Sternfeld B, Matthews KA. Lipid changes during the menopause transition in relation to age and weight: the Study of Women's Health Across the Nation. Am J Epidemiol 2009;169:1352-1361.
3. Janssen I, Powell LH, Crawford S, Lasley B, Sutton-Tyrrell K. Meno-pause and the metabolic syndrome: the Study of Women's Health Across the Nation. Arch Intern Med 2008;168:1568-1575.
4. Matthews KA, Santoro N, Lasley B, et al. Relation of cardiovascular risk factors in women approaching menopause to menstrual cycle char-acteristics and reproductive hormones in the follicular and luteal phases. J Clin Endocrinol Metab 2006;91:1789-1795.
5. Sowers MR, Matthews KA, Jannausch M, et al. Hemostatic factors and estrogen during the menopausal transition. J Clin Endocrinol Metab 2005;90:5942-5948.
6. Wildman RP, Colvin AB, Powell LH, et al. Associations of endogenous sex hormones with the vasculature in menopausal women: the Study of Women's Health Across the Nation (SWAN). Menopause 2008;15: 414-421.
7. Rosano GMC, Vitale C, Marazzi G, Volteranni M. Menopause and cardiovascular disease: the evidence. Climacteric 2007;10:19-24.
8. Chu MC, Rath KM, Huie J, Taylor HS. Elevated basal FSH in normally cycling women is associated with unfavorable lipid levels and increased cardiovascular risk. Hum Reprod 2003;18:1570-1573.
9. Murabito JM, Yang Q, Fox C, Wilson PW, Cupples LA. Heritability of age at natural menopause in the Framingham Heart Study. J Clin Endocrinol Metab 2005;90:3427-3430.
10. Castelo-Branco C, Blümel JE, Chedraui P, et al. Age at menopause in Latin America. Menopause 2006;13:706-712.
11. Gold EB, Bromberger J, Crawford S, et al. Factors associated with age at natural menopause in a multiethnic sample of midlife women. Am J Epidemiol 2001;153:865-874.
12. Luoto R, Kaprio J, Uutela A. Age at natural menopause and socio-demographic status in Finland. Am J Epidemiol 1994;139:64-76.
13. Henderson KD, Bernstein L, Henderson B, Kolonel L, Pike MC. Predictors of the timing of natural menopause in the Multiethnic Cohort Study. Am J Epidemiol 2008;167:1287-1294.
14. Vermeulen A. Environment, human reproduction, menopause, and an-dropause. Environ Health Perspect 1993;101:91-100.
15. Kok HS, van Asselt KM, van der Schuow YT, et al. Heart disease determines menopausal age rather than the reverse. J Am Coll Cardiol 2006;47:1976-1983.
16. Forges T, Monnier-Barbarino P, Leheup B, Jouvet P. Pathophysiology of impaired ovarian function in galactosaemia. Hum Reprod Update 2006;12:573-584.
17. Agarwal A, Gupta S, Sharma R. Oxidative stress and its implications in female infertilityVa clinician's perspective. Reprod Biomed Online 2005;11:641-650.
18. Chavarro JE, Rich-Edwards JW, Rosner BA, Willett WC. Protein intake and ovulatory infertility. Am J Obstet Gynecol 2008;198:210.e1-210.e7.
19. Dorjgochoo T, Kallianpur A, Gao YT, et al. Dietary and lifestyle pre-dictors of age at natural menopause and reproductive span in the Shanghai Women's Health Study. Menopause 2008;15:924-933.
20. Gratzke C, Jarajapu YP, Christ GJ, et al. Effects of long-term dietary soy treatment on female urethral morphology and function in ovariectomized nonhuman primates. J Urol 2008;180:2247-2253.
21. Lees CJ, Kaplan JR, Chen H, Jerome CP, Register TC, Franke AA. Bone mass and soy isoflavones in socially housed, premenopausal macaques. Am J Clin Nutr 2007;86:245-250.
22. Riddick NV, Czoty PW, Gage HD, et al. Behavioral and neurobiological characteristics influencing social hierarchy formation in female cyno-molgus monkeys. Neuroscience 2009;158:1257-1265.
23. Walker SE, Adams MR, Franke AA, Register TC. Effects of dietary soy protein on iliac and carotid artery atherosclerosis and gene expression in male monkeys. Atherosclerosis 2008;196:106-113.
24. Appt SE, Kaplan JR, Clarkson TB, Cline JM, Christian PJ, Hoyer PB. Destruction of primordial ovarian follicles in adult cynomolgus macaques after exposure to 4-vinylcyclohexene diepoxide: a nonhuman primate model of the menopausal transition. Fertil Steril 2006;86:1210-1216.
25. Appt SE, Clarkson TB, Chen H, et al. Serum antimüllerian hormone predicts ovarian reserve in a monkey model. Menopause 2009;16: 597-601.
26. Pederson T, Peters H. Proposal for a classification of oocytes and follicles in the mouse ovary. J Reprod Fertil 1968;17:555-557.
27. Lee MM, Gustafson ML, Ukiyama E, et al. Developmental changes in Müllerian inhibiting substance in the cynomolgus monkey, Macaca fascicularis. J Clin Endocrinol Metab 1994;78:615-621.
28. Pazol K, Wilson ME, Wallen K. Medroxyprogesterone acetate antago-nizes the effects of estrogen treatment on social and sexual behavior in female macaques. J Clin Endocrinol Metab 2004;89:2998-3006.
29. Kaplan JR, Adams MR, Anthony MS, Morgan TM, Manuck SB, Clarkson TB. Dominant social status and contraceptive hormone treat-ment inhibit atherogenesis in premenopausal monkeys. Arterioscler Thromb Vasc Biol 1995;15:2094-2100.
30. Walker SE, Register TC, Appt SE, et al. Plasma lipid-dependent and-independent effects of dietary soy protein and social status on atherogenesis in premenopausal monkeys: implications for postmeno-pausal atherosclerosis burden. Menopause 2008;15:950-957.
31. Register TC, Cann JA, Kaplan JR, et al. Effects of soy isoflavones and conjugated equine estrogens on inflammatory markers in atherosclerotic, ovariectomized monkeys. J Clin Endocrinol Metab 2005;90:1734-1740.
32. Franke AA, Custer LJ, Wilkens LR, et al. Liquid chromatographic analysis of dietary phytoestrogens from human urine and blood. J Chromatogr B Analyt Technol Biomed Life Sci 2002;777:45-59.
33. Kaplan JR, Manuck SB, Chen H. The relationship between social status and atherosclerosis in male and female monkeys as revealed by meta-analysis. Am J Primatol 2009;71:732-741.
34. Preacher KJ, Hayes AF. SPSS and SAS procedures for estimating indirect effects in simple mediation models. Behav Res Methods Instrum Comput 2004;36:717-731.
35. Anthony MS, Clarkson TB, Williams JK. Effects of soy isoflavones on atherosclerosis: potential mechanisms. Am J Clin Nutr 1998;68: 1390S-1393S.
36. Register TC. Primate models in women's health: inflammation and atherogenesis in female cynomolgus macaques (Macaca fascicularis). Am J Primatol 2009;71:766-775.
37. Bittner V. Menopause and cardiovascular risk: cause or consequence? J Am Coll Cardiol 2006;47:1984-1986.
38. Honoré EK, Williams JK, Anthony MS, Clarkson TB. Soy isoflavones enhance coronary vascular reactivity in atherosclerotic female macaques. Fertil Steril 1997;67:148-154.
39. Stroud FC, Appt SE, Wilson ME, Franke AA, Adams MR, Kaplan JR. Concentrations of isoflavones in macaques consuming standard labo-ratory monkey diet. J Am Assoc Lab Anim Sci 2006;45:20-23.
40. Muthyala RS, Ju YH, Sheng S, et al. Equol, a natural estrogenic metabolite from soy isoflavones: convenient preparation and resolution of R-and S-equols and their differing binding and biological acti-vity through estrogen receptors α and A. Bioorg Med Chem 2004;12: 1559-1567.
41. Agarwal A, Gupta S, Sikka S. The role of free radicals and antioxidants in reproduction. Curr Opin Obstet Gynecol 2006;18:325-332.
42. Jenkins DJ, Kendall CW, Connelly PW, et al. Effects of high-and low-isoflavone (phytoestrogen) soy foods on inflammatory biomarkers and proinflammatory cytokines in middle-aged men and women. Metabolism 2002;51:919-924.
43. Taŕin JJ, Pérez-Albalá S, Cano A. Oral antioxidants counteract the negative effects of female aging on oocyte quantity and quality in the mouse. Mol Reprod Dev 2002;61:385-397.
44. Burger HG, Hale GE, Robertson DM, Dennerstein L. A review of hormonal changes during the menopausal transition: focus on findings from the Melbourne Women's Midlife Health Project. Hum Reprod Update 2007;13:559-565.
45. de Vet A, Laven JSE, de Jong FH, Themmen APN, Fauser BCJM. Antimüllerian hormone serum levels: a putative marker for ovarian aging. Fertil Steril 2002;77:357-362.
46. Hale GE, Zhao X, Hughes CL, Burger HG, Robertson DM, Fraser IS. Endocrine features of menstrual cycles in middle and late reproductive age and the menopausal transition classified according to the Staging of Reproductive Aging Workshop (STRAW) staging system. J Clin Endocrinol Metab 2007;92:3060-3067.
47. La Marca A, de Leo V, Giulini S, et al. Anti-mullerian hormone in premenopausal women and after spontaneous or surgically induced menopause. J Soc Gynecol Investig 2005;12:545-548.
48. Robertson DM, Hale GE, Fraser IS, Hughes CL, Burger HG. A pro-posed classification system for menstrual cycles in the menopause tran-sition based on changes in serum hormone profiles. Menopause 2008; 15:1139-1144.
49. Sowers MR, Eyvazzadeh AD, McConnell D, et al. Anti-müllerian hormone and inhibin B in the definition of ovarian aging and the menopause transition. J Clin Endocrinol Metab 2008;93:3478-3483.
50. van Rooij IAJ, den Tonkelaar I, Broekmans FJM, et al. Anti-müllerian hormone is a promising predictor for the occurrence of the menopausal transition. Menopause 2004;11:601-606.
51. Nichols SM, Bavister BD, Brenner CA, Didier PJ, Harrison RM, Kubisch HM. Ovarian senescence in the rhesus monkey (Macaca mulatta). Hum Reprod 2005;20:79-83.
52. Richardson SJ, Senikas V, Nelson JF. Follicular depletion during the menopausal transition: evidence for accelerated loss and ultimate exhaustion. J Clin Endocrinol Metab 1987;65:1231-1237.
53. Richardson SJ, Nelson JF. Follicular depletion during the menopausal transition. Ann N Y Acad Sci 1990;592:13-20.
54. Richardson SJ. The biological basis of the menopause. Baillieres Clin Endocrinol Metab 1993;7:1-16.